scholarly journals Diagnosis and treatment of pediatric frontotemporal pits: report of 2 cases

2016 ◽  
Vol 18 (4) ◽  
pp. 471-474 ◽  
Author(s):  
Morgan Bliss ◽  
Gerald Grant ◽  
Ethan Tittler ◽  
Tina Loven ◽  
Kristen W. Yeom ◽  
...  
Keyword(s):  
Diagnosis And Treatment ◽  
Risk Of Infection ◽  
Cervical Lesions ◽  
Single Institution ◽  
Diagnosis And Management ◽  
Management Recommendations ◽  
Delays In Diagnosis

In contrast to more common nasal and cervical lesions, the frontotemporal pit is a rarely encountered lesion that is often associated with a dermoid and may track intracranially. Due to delays in diagnosis, the propensity to spread intracranially, and the risk of infection, awareness of these lesions and appropriate diagnosis and management are important. The authors present 2 cases of frontotemporal pits from a single institution. Epidemiology, presentation, and management recommendations are discussed.

scholarly journals Management of Small Bowel Neuroendocrine Tumors

2018 ◽  
Vol 14 (8) ◽  
pp. 471-482 ◽  
Author(s):  
Aaron T. Scott ◽  
James R. Howe
Keyword(s):  
Small Intestine ◽  
Small Bowel ◽  
Neuroendocrine Tumors ◽  
Multimodal Therapy ◽  
Slow Growth ◽  
Diagnosis And Treatment ◽  
Diagnosis And Management ◽  
The Past ◽  
Disease Prognosis ◽  
Delays In Diagnosis

Small bowel neuroendocrine tumors (NETs) are increasing in incidence and are now the most common primary malignancies of the small intestine. Despite this increase, the vague presentation and slow growth of these tumors lead to long delays in diagnosis, and many patients present with metastases. Patients with metastatic small bowel NETs have a favorable disease prognosis, particularly when contrasted with other GI malignancies, and benefit from aggressive, multimodal therapy. During the past decade, the options for the diagnosis and treatment of small bowel NETs have increased considerably. This review provides a practical framework for the physician who seek to understand the epidemiology, presentation, diagnosis, and management of small bowel NETs.

Orthodontic management of impacted mandibular second molars: A case series

2021 ◽  
Vol 14 (2) ◽  
pp. 98-104
Author(s):  
Andrea Cunningham ◽  
Dipali Patel ◽  
Zahra Sheriteh
Keyword(s):  
Early Diagnosis ◽  
Clinical Relevance ◽  
Case Series ◽  
Diagnosis And Treatment ◽  
Treatment Modalities ◽  
Individual Basis ◽  
Diagnosis And Management

This case series describes a number of different treatment modalities used in the management of impacted mandibular second molars (MM2s). A variety of cases is used to illustrate a number of ways in which these teeth can be managed, and to demonstrate that each case should be managed on an individual basis, taking into account the overall malocclusion. The importance of early diagnosis and management is highlighted throughout. CPD/Clinical Relevance: This case series highlights the difficulties and challenges in managing patients who present with impacted lower second molars (MM2s), and the importance of early diagnosis and treatment.

scholarly journals Interobserver reliability of teledermatology across all Fitzpatrick skin types

2016 ◽  
Vol 23 (1) ◽  
pp. 68-73 ◽  
Author(s):  
Lisa Altieri ◽  
Jenny Hu ◽  
Andrew Nguyen ◽  
Myles Cockburn ◽  
Melvin Chiu ◽  
...  
Keyword(s):  
Los Angeles ◽  
Interobserver Reliability ◽  
Diagnostic Testing ◽  
Safety Net ◽  
Primary Diagnosis ◽  
Diagnosis And Management ◽  
Dermatology Clinic ◽  
Significant Difference ◽  
Store And Forward ◽  
Management Recommendations

Introduction Demand for dermatologic services in safety net hospitals, which disproportionately serve patients with darker coloured skin, is growing. Teledermatology has the potential to increase access and improve outcomes, but studies have yet to demonstrate the reliability of teledermatology for all Fitzpatrick skin types. Methods We assessed the reliability of teledermatologists’ diagnoses and management recommendations for store-and-forward teledermatology in patients with lightly pigmented (Fitzpatrick skin types I–III) versus darkly pigmented (Fitzpatrick skin types IV–VI) skin, when compared to in-person diagnosis and management decisions. This prospective study enrolled 232 adult patients, presenting with new, visible skin complaints in a Los Angeles county dermatology clinic. Forty-seven percent of patients were Fitzpatrick skin types I–III, and 53% were Fitzpatrick skin types IV–VI. Results Percent concordance for the identical primary diagnosis was 53.2% in lighter (Fitzpatrick I–III) skin types and 56.0% in darker (Fitzpatrick IV–VI) skin types. There was no statistically significant difference in concordance rates between lighter and darker skin types for primary diagnosis. Concordance rates for diagnostic testing, clinic-based therapy, and treatments were similar in both groups of Fitzpatrick skin types. Discussion These results suggest that teledermatology is reliable for the diagnosis and management of patients with all Fitzpatrick skin types.

scholarly journals Gender differences in delays in diagnosis and treatment of tuberculosis

2007 ◽  
Vol 22 (5) ◽  
pp. 329-334 ◽  
Author(s):  
F. Karim ◽  
Md. A. Islam ◽  
A. Chowdhury ◽  
E. Johansson ◽  
V. K Diwan
Keyword(s):  
Gender Differences ◽  
Diagnosis And Treatment ◽  
Delays In Diagnosis

scholarly journals Noncarious Cervical Lesions as Abfraction: Etiology, Diagnosis, and Treatment Modalities of Lesions: A Review Article

Dentistry ◽  
2017 ◽  
Vol 07 (06) ◽  
Author(s):  
Ahmed Mohammed El Marakby ◽  
Fuad Abdo Al Sabri ◽  
Sahar A Alharbi ◽  
Shahd M Halawani
Keyword(s):  
Review Article ◽  
Diagnosis And Treatment ◽  
Treatment Modalities ◽  
Cervical Lesions

scholarly journals The case for open science: rare diseases

JAMIA Open ◽  
2020 ◽  
Vol 3 (3) ◽  
pp. 472-486
Author(s):  
Yaffa R Rubinstein ◽  
Peter N Robinson ◽  
William A Gahl ◽  
Paul Avillach ◽  
Gareth Baynam ◽  
...  
Keyword(s):  
Rare Disease ◽  
Rare Diseases ◽  
Medical Management ◽  
Open Science ◽  
Patient Data ◽  
Diagnosis And Treatment ◽  
Community Research ◽  
The Core ◽  
Delays In Diagnosis

Abstract The premise of Open Science is that research and medical management will progress faster if data and knowledge are openly shared. The value of Open Science is nowhere more important and appreciated than in the rare disease (RD) community. Research into RDs has been limited by insufficient patient data and resources, a paucity of trained disease experts, and lack of therapeutics, leading to long delays in diagnosis and treatment. These issues can be ameliorated by following the principles and practices of sharing that are intrinsic to Open Science. Here, we describe how the RD community has adopted the core pillars of Open Science, adding new initiatives to promote care and research for RD patients and, ultimately, for all of medicine. We also present recommendations that can advance Open Science more globally.

A Limitation in the Use of Office Records for Health Care Evaluation

PEDIATRICS ◽  
1975 ◽  
Vol 56 (2) ◽  
pp. 295-296
Author(s):  
Thomas Long ◽  
K. D. Rogers
Keyword(s):  
Health Care ◽  
Patient Care ◽  
Sore Throat ◽  
Specific Problem ◽  
Diagnosis And Treatment ◽  
Diagnosis And Management ◽  
Physician Office ◽  
Health Care Evaluation ◽  
Ambulatory Health Care ◽  
Care Evaluation

A potential limitation of physician office records for ambulatory health care evaluation is their completeness. Criteria used to evaluate care of a specific problem not only should be of major importance in its diagnosis and treatment but should also be likely to be recorded in the physician's records. It is possible that a physician may not record certain kinds of observations and actions even though he performs them. Further, whether or not the physician enters information in his record may not be related to his opinion about its importance for patient care. The specific questions asked in this study were whether practices deemed desirable by practitioners for diagnosis and management of sore throat of possible streptococcal origin were actually performed and, if so, whether the performance was recorded.

Abstract NS6: Born to Run: Advanced Practice Provider-Led Mobile Stroke Unit Care Measures Up to Vascular Neurologists’ Diagnosis and Management

Stroke ◽  
2017 ◽  
Vol 48 (suppl_1) ◽  
Author(s):  
Anne W Alexandrov ◽  
Wendy Dusenbury ◽  
Victoria Swatzell ◽  
Joseph Rike ◽  
Andrew Bouche ◽  
...  
Keyword(s):  
Medical Diagnosis ◽  
Treatment Decisions ◽  
Diagnosis And Treatment ◽  
Advanced Practice ◽  
Treatment Delivery ◽  
Stroke Treatment ◽  
Diagnosis And Management ◽  
Mobile Stroke Unit ◽  
Stroke Mimic ◽  
Treatment Safety

Background: Mobile Stroke Units (MSU) are growing in numbers throughout the U.S. and abroad, with numerous staffing configurations, telemedicine, and differing imaging capabilities. We aimed to test the diagnostic accuracy and treatment safety, alongside time to diagnosis and treatment delivery of a novel advanced practice provider (APP) led MSU team. Methods: We launched an MSU housing a hospital-grade Siemens Somatom CT with CTA capabilities, and hired APPs with advanced neurovascular practitioner board certification to lead field medical diagnosis and order/initiate treatment for encountered stroke patients. Consecutive MSU patients were evaluated for differences between APPs and Vascular Neurologists (VNs) diagnosis and management, and scene diagnosis and treatment times were collected. Results: Agreement between APP field medical diagnosis and MD hospital diagnosis was 100%; stroke mimic diagnosis agreement was 98%. Overall agreement for field interpretation of CT/CTA was 97%, with discrepancies not associated with stroke treatment decisions. MDs’ agreement with APPs’ identification/treatment of ICH was 100%, and IVtPA treatment decisions 98% (APPs more conservative). Scene arrival to medical diagnosis (including clinical exam and imaging completion/interpretation) ranged from 7-10 minutes, of which 4 minutes were CT/CTA start to finish times. Scene arrival to IVtPA bolus ranged from 16 minutes to 33 minutes and was driven primarily by need for control of excessive hypertension, with scene arrival to start of nicardipine premix infusion ranging from 10-14 minutes. Conclusions: Use of an APP-led MSU is safe and non-inferior to VN diagnosis/management, and may be faster than telemedicine guided MSU treatment.

Molecular Testing in the Diagnosis and Management of Hepatitis C Virus Infection

2002 ◽  
Vol 126 (3) ◽  
pp. 285-290 ◽  
Author(s):  
Raymond P. Podzorski
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Nucleic Acid ◽  
The United States ◽  
Nucleic Acid Amplification ◽  
Diagnosis And Treatment ◽  
Molecular Testing ◽  
Nucleic Acid Amplification Tests ◽  
Diagnosis And Management ◽  
Molecular Tests

Abstract Objectives.—To review hepatitis C virus (HCV), describe the types of molecular-based tests available for the diagnosis and management of HCV infection, and discuss the appropriate utilization of these tests. Data Sources.—Current information is presented from the published literature, as well as new information where available. Study Selection.—A major cause of posttransfusion and community-acquired non-A, non-B hepatitis worldwide is HCV. Approximately 4 million people in the United States are infected with HCV, resulting in 8000 to 10 000 deaths annually. Because HCV is not readily cultured, in vitro molecular-based tests have been developed for use in the diagnosis and treatment of HCV-infected patients. Molecular tests include qualitative and quantitative nucleic acid amplification tests, branched DNA tests, and HCV genotyping assays. Qualitative HCV nucleic acid amplification tests are used routinely in association with serologic tests to help make a diagnosis of infection with HCV. Quantitative HCV testing and genotyping methods have been found to be valuable tools in the treatment of infected patients. A patient's pretreatment HCV viral load and the rate of virus decline during therapy have been shown to correlate with the likelihood of long-term response to antiviral therapy. Information pertaining to the genotype of HCV infecting patients has been shown to be helpful in making recommendations regarding treatment. Certain genotypes of HCV are much more responsive to therapy, allowing a shorter course of treatment. Conclusions.—Molecular tests are valuable tools for use in the diagnosis and treatment of patients infected with HCV.

Sign in / Sign up

Export Citation Format

Share Document